Can we prevent parkinson's disease?

  title={Can we prevent parkinson's disease?},
  author={Christine R. Swanson and Samantha L Sesso and M. Emborg},
  journal={Frontiers in bioscience},
  • Christine R. Swanson, Samantha L Sesso, M. Emborg
  • Published 2009
  • Medicine
  • Frontiers in bioscience
  • Parkinson's disease (PD) is a progressive neurodegenerative disorder that affects 1 million people in the United States. Although the cause of PD remains unknown, a number of factors that increase the risk of developing this disease have been identified. Other factors that may prevent or slow down PD development and progression have also been found. In this review, we describe current basic, clinical and epidemiological findings on risk and neuroprotective factors and discuss how they can… CONTINUE READING
    10 Citations

    Tables and Topics from this paper

    Recognition and management of Parkinson’s disease during the premotor (prodromal) phase
    • 11
    • PDF
    Deuterium-L-DOPA: a Novel Means to Improve Treatment of Parkinson's Disease
    The PPAR-γ agonist pioglitazone modulates inflammation and induces neuroprotection in parkinsonian monkeys
    • 140
    Lay persons' beliefs and knowledge about Parkinson's disease: prevalence and socio-demographic correlates.
    • 4


    Genetic clues to the pathogenesis of Parkinson's disease
    • 250
    • Highly Influential
    • PDF
    Parkinson's Disease Mechanisms and Models
    • 4,164
    • Highly Influential
    • PDF
    Neuroprotection in Parkinson disease: mysteries, myths, and misconceptions.
    • 255
    • Highly Influential
    Evaluation of animal models of Parkinson's disease for neuroprotective strategies
    • M. Emborg
    • Psychology, Medicine
    • Journal of Neuroscience Methods
    • 2004
    • 156
    Pesticides and Parkinson’s Disease—Is There a Link?
    • 370
    • Highly Influential
    • PDF
    Cyclooxygenase-2 is instrumental in Parkinson's disease neurodegeneration
    • 584
    • PDF
    Developmental pesticide exposures and the Parkinson's disease phenotype.
    • 49